No photo of Shreerang Sirdesai

Shreerang Sirdesai

Dr

20182018
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2018

  • 2 Meeting Abstract
  • 1 Article

Phase 2 Trial of the Combination of Ixazomib, Thalidomide and Dexamethasone (ITD) in Relapsed/Refractory Myeloma: Planned Preliminary Analysis

Bergin, K., Yuen, F., Wallington-Beddoe, C. T., Kalff, A., Sirdesai, S., Reynolds, J. & Spencer, A., 29 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 3265.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Preliminary Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) MM17 Trial: Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone (KTd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy: Blood 2018 132:3279

Spencer, A., Quach, H., Horvath, N., Kerridge, I. H., Yuen, F., Lee, E. S-H., Morris, E. S., Kalff, A., Bergin, K., Sirdesai, S., Gorniak, M., Mithraprabhu, S., Khong, T. & Reynolds, J., 29 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 3279.

Research output: Contribution to journalMeeting AbstractOtherpeer-review